Bering Secures FDA Clearance for AI-Based Chest X-Ray Triage Solution
FDA 510(k) clearance for AI Radiology software product, targeting emergency cases found on chest X-Rays.
- FDA 510(k) clearance for AI Radiology software product, targeting emergency cases found on chest X-Rays.
- Bering to accelerate business in the US market, leveraging new and existing partnerships
LONDON, Dec. 6, 2023 /PRNewswire/ -- Bering Limited, a London-based medical AI company, today announced it received US Food and Drug Administration (FDA) 510(k) clearance for its AI-powered chest X-Ray triage solution, 'BraveCX'. - With the FDA clearance, the company is now able to commercially provide the AI solution to medical professionals and healthcare institutions in the US.
- FDA clearance means BraveCX prioritises patient safety, whilst still delivering the most advanced Risk Stratification algorithms where they are needed the most."